BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Zydus’ Methylene Blue Injection Gains USFDA Nod December 8, 2023 The approval was granted to Methylene Blue Injection in 10mg/2ml and 50mg/5ml formulations, allowing it to market in the US. The novel injection is an oxidation-reduction agent indicated for treating pediatric and adult patients with acquired methemoglobinemia.
Zydus Lifesciences Receives USFDA Approval for Generic Heart Failure Treatment Drug December 4, 2023 Zydus Lifesciences, a leading pharmaceutical player, has secured final approval from the US Food and Drug Administration (USFDA) for its generic version of Ivabradine tablets to treat heart failure.
DeepTek.ai's CXR Analyser Gains FDA Approval for Chest X-ray AI Solution October 17, 2023 The advanced technology utilises deep learning algorithms to detect anomalies in chest X-rays, offering automated analysis and precise identification of suspicious areas to aid clinicians in accurate interpretations.
Page 1 of 1
